Nicholas Counsell

Also affiliated with London Cancer, CRUK Lung Cancer Centre of Excellence, University College London

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma”.

Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma

European Journal of Cancer(2021)10.1016/j.ejca.2021.09.046

N/A

1.3DataRank · unranked

55 citations

Yoko Takahashi, Mario Turri‐Zanoni, Jacklyn Liu, Nicholas Counsell, Mario Hermsen +95 more

International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System

Journal of Neurological Surgery Part B Skull Base(2022)10.1055/s-0042-1750178

N/A

0DataRank · unranked

36 citations

Yoko Takahashi, Mario Turri‐Zanoni, Marco Ferrari, Jacklyn Liu, Nicholas Counsell +64 more

126 | THE EARLY‐STAGE CLASSIC HODGKIN LYMPHOMA INTERNATIONAL PROGNOSTICATION INDEX (E‐HIPI): AN INDIVIDUALIZED PREDICTION MODEL UTILIZING OBJECTIVE AND CONTINUOUS VARIABLES

Hematological Oncology(2025)10.1002/hon.70093_126

N/A

0DataRank · unranked

0 citations

Angie May Rodday, Matthew J. Maurer, Jenica Upshaw, Nicholas Counsell, Sabrina Rossetti +19 more